Abstract:Although the use of bioresorbable materials in stent production is thought to improve long-term safety compared to their durable counterparts, a recent FDA report on the 2-year follow-up of the first FDA-approved bioresorbable vascular stent showed an increased occurrence of major adverse cardiac events and thrombosis in comparison to the metallic control. In order to overcome the issues of first generation bioresorbable polymers, a series of polyethylene glycol-functionalized poly-L-lactide-co-ε-caprolactone copolymers with varying lactide-to-caprolactone content is developed using a novel one-step PEG-functionalization and copolymerization strategy. This approach represents a new facile way toward surface enhancement for cellular interaction, which is shown by screening these materials regarding their cyto- and hemocompatibility in terms of cytotoxicity, hemolysis, platelet adhesion, leucocyte activation and endothelial cell adhesion. By varying the lactide-to-caprolactone polymer composition, it is possible to gradually affect endothelial and platelet adhesion which allows fine-tuning of the biological response based on polymer chemistry. All polymers developed were non-cytotoxic, had acceptable leucocyte activation levels and presented non-hemolytic (<2% hemolysis rate) behavior except for PLCL-PEG 55:45 which presented hemolysis rate of 2.5% ± 0.5. Water contact angles were reduced in the polymers containing PEG functionalization (PLLA-PEG: 69.8° ± 2.3, PCL-PEG: 61.2° ± 7.5) versus those without (PLLA: 79.5° ± 3.2, PCL: 76.4° ± 10.2) while the materials PCL-PEG550, PLCL-PEG550 90:10 and PLCL-PEG550 70:30 demonstrated best endothelial cell adhesion. PLLA-PEG550 and PLCL-PEG550 70:30 presented as best candidates for cardiovascular implant use from a cytocompatibility perspective across the spectrum of testing completed. Altogether, these polymers are excellent innovative materials suited for an application in stent manufacture due to the ease in translation of this one-step synthesis strategy to device production and their excellent in vitro cyto- and hemocompatibility.

Bioresorbable PPDO Sliding-Lock Stents with Optimized FDM Parameters for Congenital Heart Disease Treatment.

3D-Printed Poly(p-Dioxanone)/graphene Oxide Composite Bioresorbable Stents for Congenital Heart Disease Treatment

Composite self-expanding bioresorbable prototype stents with reinforced compression performance for congenital heart disease application: Computational and experimental investigation

Mechanical properties and in vivo performance of a novel sliding-lock bioabsorbable poly- p -dioxanone stent

Development of a polycaprolactone/poly(p-dioxanone) bioresorbable stent with mechanically self-reinforced structure for congenital heart disease treatment.

3D-Printed Poly (P-Dioxanone) Stent for Endovascular Application: In Vitro Evaluations

A Novel Braided Biodegradable Stent for Use in Congenital Heart Disease: Short-term Results in Porcine Iliac Artery

Cytocompatibility Evaluation of a Novel Series of PEG-Functionalized Lactide-Caprolactone Copolymer Biomaterials for Cardiovascular Applications

3D-Printed Bioresorbable Stent Coated with Dipyridamole-Loaded Nanofiber for Restenosis Prevention and Endothelialization

Braided Bioresorbable Cardiovascular Stents Mechanically Reinforced by Axial Runners.

Bio-resorbable polymer stents: a review of material progress and prospects

3D printed stents using Fused deposition modelling

Multi-objective optimisation of material properties and strut geometry for poly(L-lactic acid) coronary stents using response surface methodology

Materials and Manufacturing Technologies Available for Production of a Pediatric Bioabsorbable Stent

Improved Mechanical Properties of Poly( L ‐lactic Acid) Stent Coated by Poly( D , L ‐lactic Acid) and Poly( L ‐lactic‐co‐glycolic Acid) Biopolymer Blend

Development and characterization of a coronary polylactic acid stent prototype generated by selective laser melting

[Design and mechanical properties of biodegradable polymeric stent]

Computational and Experimental Investigation into Mechanical Performances of Poly-L-Lactide Acid (PLLA) Coronary Stents

Design, Characterization, and 3D Printing of Cardiovascular Stents with Zero Poisson’s Ratio in Longitudinal Deformation

Advances in the development of biodegradable coronary stents: A translational perspective

Direct 3D printing of thin-walled cardiovascular stents with negative Poisson's ratio (NPR) structure and functional metallic coating